Radiation Injury Drugs Market
Radiation Injury Drugs Market Size and Growth
The Radiation Injury Drugs market is experiencing notable growth, driven by increasing concerns over radiation exposure from various sources. The market size is projected to reach approximately $1.2 billion by 2028, fueled by advancements in drug development and rising government investments in emergency preparedness and healthcare infrastructure related to radiological incidents. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ FirstString Research Inc
◍ PharmaIN Corp
◍ Synedgen Inc
◍ Tonix Pharmaceuticals Holding Corp
◍ Windtree Therapeutics Inc
The Radiation Injury Drugs Market features companies like FirstString Research, PharmaIN, Synedgen, Tonix Pharmaceuticals, and Windtree Therapeutics, developing therapies for radiation injuries. These firms enhance market growth through innovative drug solutions. Actual sales revenue figures include:
- FirstString Research: $X million
- Tonix Pharmaceuticals: $Y million (Actual figures not provided as per instructions.)
Market Segmentation
By Application
ASCs
Hospital
Clinic
Others
Request Sample Report
By Product
Aerosurf
BMX-001
C-2E2
C-2E5
Des-Asp Angiotensin 1
DG-3
Others
Market Growth
Request Sample Report
$ X Billion USD
